Towards equity in immunisation.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Jan 2019
Historique:
entrez: 17 1 2019
pubmed: 17 1 2019
medline: 27 6 2020
Statut: ppublish

Résumé

In the World Health Organization (WHO) European Region, differences in uptake rates of routine childhood immunisation persist within and among countries, with rates even falling in some areas. There has been a tendency among national programmes, policymakers and the media in recent years to attribute missed vaccinations to faltering demand or refusal among parents. However, evidence shows that the reasons for suboptimal coverage are multifactorial and include the social determinants of health. At the midpoint in the implementation of the European Vaccine Action Plan 2015-2020 (EVAP), national immunisation programmes should be aware that inequity may be a factor affecting their progress towards the EVAP immunisation targets. Social determinants of health, such as individual and household income and education, impact immunisation uptake as well as general health outcomes - even in high-income countries. One way to ensure optimal coverage is to make inequities in immunisation uptake visible by disaggregating immunisation coverage data and linking them with already available data sources of social determinants. This can serve as a starting point to identify and eliminate underlying structural causes of suboptimal uptake. The WHO Regional Office for Europe encourages countries to make the equitable delivery of vaccination a priority.

Identifiants

pubmed: 30646979
doi: 10.2807/1560-7917.ES.2019.24.2.1800204
pmc: PMC6337057
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Références

J Epidemiol Community Health. 2007 Jun;61(6):473-8
pubmed: 17496254
Bull World Health Organ. 2008 Feb;86(2):140-6
pubmed: 18297169
Euro Surveill. 2010 Jul 08;15(27):32-9
pubmed: 20630143
J Infect Dis. 2012 Mar;205 Suppl 1:S20-7
pubmed: 22315382
Hum Vaccin Immunother. 2012 Mar;8(3):293-301
pubmed: 22327490
PLoS One. 2012;7(9):e43416
pubmed: 23028452
Vaccine. 2013 Apr 18;31 Suppl 2:B103-7
pubmed: 23598470
J Epidemiol Community Health. 2014 Jan;68(1):57-63
pubmed: 23986492
Vaccine. 2013 Nov 19;31(48):5687-92
pubmed: 24120549
Euro Surveill. 2014 Jan 16;19(2):null
pubmed: 24457007
Vaccine. 2014 Jun 5;32(27):3438-44
pubmed: 24721529
BMC Public Health. 2014 Jun 21;14:634
pubmed: 24952656
Br Med Bull. 2015 Mar;113(1):5-14
pubmed: 25649959
BMJ Open. 2015 May 19;5(5):e006422
pubmed: 25991445
Soc Sci Med. 2015 Sep;140:104-17
pubmed: 26210658
Vaccine. 2015 Sep 22;33(39):5188-95
pubmed: 26254978
BMC Public Health. 2016 Feb 19;16:172
pubmed: 26895838
Vaccine. 2016 May 23;34(24):2635-43
pubmed: 27109562
J Epidemiol Community Health. 2017 Jan;71(1):87-97
pubmed: 27535769
Hum Vaccin Immunother. 2016 Oct 2;12(10):2704-2706
pubmed: 27552642
Lancet Glob Health. 2016 Oct;4(10):e726-35
pubmed: 27569362
Bull World Health Organ. 2016 Nov 1;94(11):794-805B
pubmed: 27821882
Glob Health Action. 2016 Dec 16;9:34247
pubmed: 27989275
BMC Public Health. 2017 Mar 14;17(1):254
pubmed: 28288596
Vaccine. 2018 Oct 22;36(44):6556-6558
pubmed: 28830694
Expert Rev Vaccines. 2017 Nov;16(11):1107-1118
pubmed: 28914112

Auteurs

Tammy Boyce (T)

Independent consultant, Cardiff, United Kingdom.

Amelie Gudorf (A)

Independent consultant, Copenhagen, Denmark.

Catharina de Kat (C)

Vaccine-preventable Diseases and Immunization programme, World Health Organization Regional Office for Europe, Copenhagen, Denmark.

Mark Muscat (M)

Vaccine-preventable Diseases and Immunization programme, World Health Organization Regional Office for Europe, Copenhagen, Denmark.

Robb Butler (R)

Vaccine-preventable Diseases and Immunization programme, World Health Organization Regional Office for Europe, Copenhagen, Denmark.

Katrine Bach Habersaat (KB)

Vaccine-preventable Diseases and Immunization programme, World Health Organization Regional Office for Europe, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH